newsfilter
← Latest News
GlobeNewswire·

Aligos Therapeutics to Present at the Cantor Global Healthcare Conference

  • Aligos Therapeutics (NASDAQ: ALGS) announced that management will present at the Cantor Global Healthcare Conference.
  • The fireside chat is scheduled for Wednesday, September 9, 2026, at 8:00 am ET.
  • The live presentation can be accessed via the "Investors" page on www.aligos.com, with a replay available for at least 30 days.
  • Aligos is a clinical-stage biotech company focused on developing therapies for liver and viral diseases, including chronic hepatitis B virus infection.
  • The press release includes forward-looking statements subject to risks related to drug development, clinical trials, regulatory approval, and capital resources.
  • Investor contact information is provided for Jordyn Tarazi, Vice President of Investor Relations & Corporate Communications.